Compound Detail

CHEMBL5422119

Enter ChEMBL ID:

Free Research Context This compound will appear in recent viewed items on the research home for this browser.

CCn1ccc2c(-c3nc4c(-c5cc(OC)c(OC)c(OC)c5)nccc4[nH]3)cccc21

ChEMBL ↗ Properties Compare Identifier

Basic Information

ChEMBL ID	CHEMBL5422119
Phase	Preclinical
Structure Type	MOL
InChI Key	TUVRQOSSRQJXKQ-UHFFFAOYSA-N

Targets

Activities

Assay Types

PK Parameters

Publications

Known Names

428.5

MW (Da)

5.29

ALogP

HBA

HBD

74.2

PSA (Å²)

0.40

QED

Ro5 Violations

Rot. Bonds

Availability	Unknown
Chirality	Unknown

First in Class Prodrug

IC50 4 meas. best 7.96

Target	Type	Best pChEMBL	Mean pChEMBL	Best (nM)	# Data
HepG2 CHEMBL395	IC50	7.96	7.96	11.0	1
B16-F10 CHEMBL612656	IC50	7.75	7.75	18.0	1
MCF7 CHEMBL387	IC50	7.66	7.66	22.0	1
HeLa CHEMBL399	IC50	7.54	7.54	29.0	1

Top measurements by pChEMBL value

Target	Type	Rel.	Value	Units	pChEMBL	Assay	PubMed
HepG2	IC50	=	11.0	nM	7.96	Antiproliferative activity against human HepG2 cells assessed as inhibition of c...	37145846
B16-F10	IC50	=	18.0	nM	7.75	Antiproliferative activity against mouse B16-F10 cells assessed as inhibition of...	37145846
MCF7	IC50	=	22.0	nM	7.66	Antiproliferative activity against human MCF7 cells assessed as inhibition of ce...	37145846
HeLa	IC50	=	29.0	nM	7.54	Antiproliferative activity against human HeLa cells assessed as inhibition of ce...	37145846

PubMed	DOI	Target Context	# Activities
37145846	10.1021/acs.jmedchem.3c00011	MCF7	1
37145846	10.1021/acs.jmedchem.3c00011	B16-F10	1
37145846	10.1021/acs.jmedchem.3c00011	HeLa	1
37145846	10.1021/acs.jmedchem.3c00011	HepG2	1

Data from ChEMBL 36 via Core Engine